FDA Lifts Final Regulatory Restrictions on RosiglitazoneFDA Lifts Final Regulatory Restrictions on Rosiglitazone

The FDA pulls the plug on its prior risk evaluation and mitigation strategy for rosiglitazone-containing type 2 diabetes medicines. News Alerts

Source: theHeart.org - December 16, 2015 Category: Cardiology Tags: Diabetes & Endocrinology News Alert Source Type: news